These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32125390)

  • 1. Rising Prices and Health Care "Empires".
    Bindman AB
    JAMA; 2020 Mar; 323(9):815-816. PubMed ID: 32125390
    [No Abstract]   [Full Text] [Related]  

  • 2. Market-based solutions to antitrust threats--the rejection of the Partners settlement.
    Herzlinger RE; Richman BD; Schulman KA
    N Engl J Med; 2015 Apr; 372(14):1287-9. PubMed ID: 25738542
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-Market Mergers in Healthcare: Adapting Antitrust Regulation to Address a Growing Concern.
    Lopatka TJ
    Cornell Law Rev; 2017 Apr; 102(3):821-52. PubMed ID: 28379657
    [No Abstract]   [Full Text] [Related]  

  • 4. Special report on antitrust. New antitrust merger guidelines.
    Enders RJ
    Health Care Law Newsl; 1992 Aug; 7(8):13-7. PubMed ID: 10121309
    [No Abstract]   [Full Text] [Related]  

  • 5. The antitrust hurdles to mergers and acquisitions: failing hospitals and postmerger efficiencies.
    Baehr RA; Furlong MJ
    Top Health Care Financ; 1991; 17(3):10-20. PubMed ID: 2028462
    [No Abstract]   [Full Text] [Related]  

  • 6. Health care collaboration, antitrust, and the 1992 merger guidelines: do competition and cost effective co-operation conflict?
    Adler H
    J Health Hosp Law; 1992 Jul; 25(7):193-200. PubMed ID: 10123591
    [No Abstract]   [Full Text] [Related]  

  • 7. Policy implications of recent hospital competition studies.
    Allen R
    J Health Econ; 1992 Oct; 11(3):347-51. PubMed ID: 10122543
    [No Abstract]   [Full Text] [Related]  

  • 8. What is driving health care cost increases?
    PHC4 FYI; 2003 Jan; (15):1-3. PubMed ID: 12542075
    [No Abstract]   [Full Text] [Related]  

  • 9. Hospital markets and competition: implications for antitrust policy.
    Nguyen NX; Derrick FW
    Health Care Manage Rev; 1994; 19(1):34-43. PubMed ID: 8206760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTC weighs next move in Mo. merger. Agency lost its antitrust case in court but can still pursue an administrative complaint.
    Taylor M
    Mod Healthc; 1999 Aug; 29(32):34. PubMed ID: 10558243
    [No Abstract]   [Full Text] [Related]  

  • 11. Ulterior motive? FTC searching for evidence with look back at merger.
    Taylor M
    Mod Healthc; 2004 Feb; 34(7):16. PubMed ID: 15015470
    [No Abstract]   [Full Text] [Related]  

  • 12. Addressing Consolidation in Health Care Markets.
    Dafny L
    JAMA; 2021 Mar; 325(10):927-928. PubMed ID: 33507224
    [No Abstract]   [Full Text] [Related]  

  • 13. Health care alliances--good medicine for an ailing health care industry, or antitrust illnesses to fence in?
    Sander NL
    Spec Law Dig Health Care Law; 1997 Dec; (226):9-49. PubMed ID: 10175045
    [No Abstract]   [Full Text] [Related]  

  • 14. Competitive duel. FTC lawyer says Evanston deal caused 'sea change'.
    Taylor M
    Mod Healthc; 2005 Feb; 35(7):8-9. PubMed ID: 15736785
    [No Abstract]   [Full Text] [Related]  

  • 15. Say uncle. FTC fights to control hospital mergers.
    Neil R
    Mater Manag Health Care; 2003 Apr; 12(4):16-9. PubMed ID: 12854202
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitrust enforcement encourages health care providers to cooperate procompetitively.
    Marx D; Murphy CM
    Ann Health Law; 1994; 3():1-27. PubMed ID: 10139972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purchase of OrNda adds bulk to No. 2 chain Tenet.
    Shinkman R; Japsen B; Morrissey J
    Mod Healthc; 1996 Oct; 26(43):2-3, 16. PubMed ID: 10162881
    [No Abstract]   [Full Text] [Related]  

  • 18. HMO mergers: estimating impact on premiums and costs.
    Christianson JB; Feldman RD; Wholey DR
    Health Aff (Millwood); 1997; 16(6):133-41. PubMed ID: 9444820
    [No Abstract]   [Full Text] [Related]  

  • 19. Changing antitrust prospects for hospital mergers.
    O'Malley S
    Health Syst Lead; 1997 Jan; 4(1):4-12. PubMed ID: 10164539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Back in business. Suit against N.Y. merger shows feds' antitrust concern.
    Bellandi D
    Mod Healthc; 1997 Jun; 27(24):2. PubMed ID: 10168234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.